1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

  • November 2015
  • -
  • International Market Analysis Research and Consult
  • -
  • 47 pages

China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent – making it the diabetes capital of the world.

The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.

China’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

IMARC’s new report “China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Chinese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:

Focus of the Analysis:

Historical, current and future prevalence of diabetes in China
Historical, current and future prevalence of type-1 and type-2 diabetes in China
Historical, current and future prevalence of diabetes in the urban and rural regions in China
Historical, current and future prevalence of diabetes among males and females in China
Historical, current and future prevalence of diabetes among various age groups in China
Historical, current and future diagnosis rates for diabetes in China
Historical, current and future drug treatment rates for diabetes in China
Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

Performance of the Oral Antidiabetics market in China
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese Insulin market and its dynamics:

Focus of the Analysis:

Performance of the Insulin market in China
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:

Focus of the Analysis:

Performance of the diabetes diagnostics market in China
Market Segmentation
Key players
Market outlook

Table Of Contents

China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics
1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications
4 KeyFactors Driving the Diabetes Market in China
5 China Diabetes Epidemiology
5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
5.6 Diabetes Diagnosis and Drug Treatment Rates
6 China Diabetes Market
6.1 Historical Market Trends (2007-2014)
6.2 Market Breakup by Segment (2007-2014)
6.3 China Oral Antidiabetics Market
6.3.1 Historical Market Trends (2007-2014)
6.3.2 Market Breakup by Class (2007-2014)
6.3.3 Market Shares of Key Players
6.3.4 Market Outlook (2015-2020)
6.4 China Insulin Market
6.4.1 Historical Market Trends (2015-2020)
6.4.2 Market Breakup by Class
6.4.3 Market Shares of Key Players
6.4.4 Market Outlook (2015-2020)
6.5 Market Outlook (2015-2020)
7 China Diabetes Diagnostics Market
7.1 Historical Market Trends (2007-2014)
7.2 Market Segmentation
7.3 Key Players
7.4 Market Outlook (2015-2020)

List of Figures

Figure 3 1: The Impact of Diabetes on the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: China: Overweight and Obese Population (in Millions), 2007, 2014 and 2020
Figure 4 2: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 4 3: Global: Breakup of Diabetes Patients by Region (in %), 2014 and 2030
Figure 5 1: China: Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 2: China: Total Number of Diabetes Patients (in Millions), 2015 - 2020
Figure 5 3: China (Type1 and Type2): Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 4: China (Type1 and Type2): Total Number of Diabetes Patients (in Millions) 2015 - 2020
Figure 5 5: China (Urban and Rural): Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 6: China (Urban and Rural): Total Number of Diabetes Patients (in Millions), 2015 - 2020
Figure 5 7: China (Male and Female): Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 8: China (Male and Female): Total Number of Diabetes Patients (in Millions), 2015 - 2020
Figure 5 9: China: Total Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (in Millions), 2007- 2014
Figure 5 10: China: Total Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (in Millions), 2015 - 2020
Figure 5 11: China: Total Diagnosed and Drug Treated Diabetes Population (in Millions), 2007- 2014
Figure 5 12:China: Total Diagnosed and Drug Treated Diabetes Population (in Millions), 2015 - 2020
Figure 6 1: China: Diabetes Market (in Million US$), 2007-2014
Figure 6 2: China: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2007-2014
Figure 6 3: China: Oral Antidiabetics Market (in Million US$), 2007-2014
Figure 6 4: China: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2007-2014
Figure 6 5: China: Oral Antidiabetics Market: Sales Share of Key Players (in %)
Figure 6 6: China: Oral Antidiabetics Market Forecast (in Million US$), 2015-2020
Figure 6 7: China: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2015 and 2020
Figure 6 8: China: Insulin Market (in Million US$), 2007-2014
Figure 6 9: China: Insulin Market: Sales Share of Key Classes (in %), 2014
Figure 6 10: China: Insulin Market: Sales Share of Key Players (in %)
Figure 6 11: China: Insulin Market Forecast (in Million US$), 2015-2020
Figure 6 12: China: Insulin Market Forecast: Sales Share of Key Classes (in %), 2015 and 2020
Figure 6 13: China: Diabetes Market Forecast (in Million US$), 2015-2020
Figure 6 14: China: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2015-2020
Figure 7 1: China: Diabetes Diagnostics Market (in Million US$), 2007-2014
Figure 7 2: China: Diabetes Diagnostics Market Forecast (in Million US$), 2015-2020

List of Tables

Table 2 1: China: Diabetes Epidemiology: Executive Summary
Table 2 2: China: Diabetes Market: Executive Summary
Table 3 1: Diagnosis of Diabetes
Table 4 1: China: Overweight and Obesity Statistics, 2006, 2010 and 2014
Table 4 2: China: Urban and Rural Population Breakup (in Millions), 1991, 2001, 2011 and 2014
Table 4 3: Global: Diabetes Population Breakup by Country (in 000's), 2014 and 2020
Table 4 4: Global: Market Size and Growth Rates of Top Emerging and Developed Diabetes Drug Markets
Table 5 1: China: Total Prevalence and Number of Diabetes Patients, 2007, 2014 and 2020
Table 5 2: China (Type1 and Type2): Total Prevalence and Number of Diabetes Patients, 2007, 2014 and 2020
Table 5 3: China (Urban and Rural): Total Prevalence and Number of Diabetes Patients, 2007, 2014 and 2020
Table 5 4: China (Male and Female): Total Prevalence and Number of Diabetes Patients, 2007, 2014 and 2020
Table 5 5: Total Prevalence and Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (In Millions), 2007, 2014 and 2020
Table 5 6: China: Total Diagnosed and Drug Treated Diabetes Population, 2007, 2014 and 2020

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

  • $ 4995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence ...

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Diabetic Gastroparesis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Diabetic Gastroparesis fo ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.